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Abstract 
High output ileostomies are important complications of stoma formation following 
bowel surgery. Adequate management of such stomas might prevent severe 
morbidity and mortality when this potentially fatal complication develops. In this 
case report, we describe a female patient with a recent ileostomy formation following 
panproctocolectomy for ulcerative colitis who presented with progressively increasing 
shortness of breath. The patient was found to have a hypochloraemic metabolic acidosis 
on arterial blood gases. She rapidly improved with adequate sodium and fluid 
replacement and with the use of a course of proton pump inhibitors. This case highlights 
the importance of recognising high output ileostomies early and important management 
issues in their regard. 
Introduction 
Ileostomy formation is occasionally required in patients with complicated 
inflammatory bowel disease requiring colonic resection. This procedure can lead to a 
number of recognised complications including stomal obstruction, stomal prolapse, skin 
erythema and ileal inflammation. A less commonly described complication is high output 
ileostomy which occurs when there is a disproportionate fluid and electrolyte loss 
through the stoma. In the first few days after ileostomy formation, there is frequently an 
increased stool effluent through the stoma, but this rapidly decreases because of 
‘ileostomy adaptation’ [1]. The normal output through an ileostomy following a total  
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colectomy is between 400 and 600 g of stools daily. In a high output ileostomy, stool 
output is more than 1,000 g daily, which can result in severe dehydration and electrolyte 
imbalance [2]. While impaired ‘ileostomy adaptation’ has been used to describe the 
pathogenesis of high output ileostomies, there is now an increasing body of evidence 
suggesting that enteral infection with Clostridium difficile might contribute to the cause 
[3, 4]. While it is difficult to estimate the incidence of this complication, it is certainly an 
important issue which has a significant effect on patients’ quality of life and significant 
morbidity and mortality. Therefore adequate management of high output ileostomies is 
important. In this article we present a patient with a high output ileostomy and describe 
the physiological changes that are believed to occur and the recommended management 
issues of this important complication. 
Case Report 
A 42-year-old female lawyer with a 4-year history of ulcerative proctitis presented to our hospital 
with a 2-week history of worsening shortness of breath at rest, which was worse on exertion. Her colitis 
was severe and progressive and had extended into a pancolitis. She had failed medical therapy (which 
consisted of mesalazine 3.2 g daily since diagnosis, mesalazine enemas, azathioprine at a dose of 
2.5 mg/kg for the previous 4 years and infliximab at a dose of 5 mg/kg every 6 weeks for the previous 
3 years), and 2 months before her current presentation she had undergone a panproctocolectomy with 
ileal pouch formation and ileoanal anastomosis. A defunctioning loop ileostomy was temporarily 
performed. Over the years she had also required regular steroids in view of clinically active disease 
(raised partial Mayo score for ulcerative colitis), blood tests as manifested by anaemia and raised 
inflammatory markers and endoscopically active disease. Multiple stool samples for culture, ova, cysts, 
parasites, C. difficile toxins and colonoscopic biopsies had ruled out co-existent superinfection. The 
patient had persistently refused to undergo colectomy until recently. 
The patient had no other symptoms besides shortness of breath. On initial assessment she was 
tachycardic with a heart rate of 130 beats per minute and tachypnoeic with a respiratory rate of 
30 breaths per minute and an SpO2 of 93%. The rest of the examination was within normal limits. 
An electrocardiogram revealed a sinus tachycardia with a P pulmonale. Chest X-ray was normal. In 
view of her symptoms, recent surgery and the above findings an echocardiogram was performed, 
which revealed a hypocontractile right ventricle. A ventilation-perfusion scan excluded any underlying 
pulmonary emboli. A CT pulmonary angiogram showed no lung pathology and no evidence of 
pulmonary embolism. Meanwhile her initial blood investigations revealed a hypochloraemic metabolic 
acidosis on a background of dehydration as indicated in table 1. On more detailed questioning, she had 
lost 6 kg since her surgery and had an effluent through the stoma of more than 2 litres per day. A 
diagnosis of high output stoma was therefore made. Other possible causes of high output stomas such as 
intraabdominal sepsis, bowel obstruction and infective enteritis were ruled out through the appropriate 
tests.  
She was managed with 1 litre 0.9% saline 12-hourly and oral fluids with Diarolyte sachets (0.47 g 
sodium chloride per sachet) and an isotonic energy drink (0.11 g sodium chloride per 240 ml of 
fluid). The patient was not keen on having codeine or Lomotil to slow down the output through 
the stoma. Thus, she was prescribed omeprazole 40 mg twice daily orally which resulted in a decrease 
in the effluent through the stoma. On starting this treatment her condition improved rapidly and she 
was discharged from hospital 6 days later, by which time her blood tests had all normalized. After 
3 months the dose of omeprazole was gradually reduced and then stopped and the patient underwent 
closure of her stoma. Currently she is asymptomatic, has gained weight and is not taking any 
medications.  
Case Rep Gastroenterol 2011;5:212–216 
DOI: 10.1159/000326928 
Published online: 
April 13, 2011 
© 2011 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
 
 
214
Discussion 
‘Ileostomy adaptation’ refers to the physiological process that occurs in the small 
intestine whereby faecal output through a stoma decreases in volume and becomes less 
fluid. This tends to occur within one to two weeks after ileostomy formation, but may 
take up to two years [1]. Adaptation is quicker and more pronounced in the ileum rather 
than in the jejunum. Pathophysiologically, ‘ileostomy adaptation’ requires cell hyperplasia 
and increased mucosal surface area with an increase in bowel circumference, an increase 
in length and bowel wall thickness, and an increase in villus height and crypt depth. 
Proctocolectomy and the establishment of an ileostomy leads to increased fluid and 
electrolyte losses even when adaptation is complete, and such patients are susceptible to 
salt and electrolyte depletion [2, 5]. A possible complication of this disproportionate 
increased output of water and electrolytes is a high output ileostomy. This can present 
itself with dehydration, prerenal impairment, hyponatreamia and hypokalaemia [6]. Our 
patient presented with prerenal impairment and hyponatreamia associated with a 
hypochloraemic metabolic acidosis. Serum gastrin is raised in patients who have 
undergone bowel resection [7, 8]. Hypergastrinaemia has been shown to cause diarrhoea, 
possibly due to hyperacidity in the stomach. In fact, patients with gastrinomas tend to 
present with diarrhoea as their initial complaint in up to 90% of cases [9]. 
In the management of high output ileostomies with marked electrolyte and water 
depletion, replacing fluids by administering 2–4 litres/day of intravenous normal saline is 
of paramount importance. Keeping the patient starved initially is also important since the 
net output is driven by the oral intake. Treatment for high output from a stoma begins 
with the patient restricting the total amount of both oral hypotonic and hypertonic fluids 
to less than 500 ml per day. The addition of a glucose-saline replacement solution 
(90 mmol/l sodium or more) is required to make up the total fluid intake.  
Loperamide and codeine phosphate reduce intestinal motility and thus decrease 
water and sodium output from an ileostomy by approximately 20–30%. Loperamide is 
preferred over codeine phosphate as it is not sedative or addictive and does not cause fat 
malabsorption. If tablets or capsules are seen unchanged in stool or stomal output, they 
can be crushed, opened, mixed with water, or put on food. 
Drugs that reduce gastric acid secretion (for example, the H2 antagonists or proton 
pump inhibitors or the somatostatin analogue octreotide) are also commonly used. 
Ranitidine (300 mg orally twice daily) and omeprazole (40 mg orally daily or 
intravenously twice daily) reduce stomal output, particularly in those with a net secretory 
output and generally in those with an output exceeding 2 litres every day. Omeprazole is 
readily absorbed in the duodenum and upper small bowel but if less than 50 cm of 
jejunum remains, it may need to be given intravenously. These drugs, which inhibit 
gastric acid secretion, are as effective as octreotide (50 mg subcutaneously twice daily) in 
reducing the volume of stomal output, but they do not change the absorption of 
electrolytes and do not reduce stomal output enough to reduce the severity of intestinal 
failure. Thus, electrolyte replacement will still be necessary.  
In adults, octreotide reduces ileostomy diarrhoea and large volume jejunostomy 
output. The greatest reductions in intestinal output are in those with a net secretory 
output, and the volume of parenteral supplements needed may be reduced. The reduction 
in sodium output parallels that of intestinal output while magnesium balance is  
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unchanged. Total energy and nitrogen absorption are not significantly changed while fat 
absorption may be unchanged or reduced. The effect of octreotide is maintained in the 
long term. Long-acting octreotide or somatostatin preparations have not been assessed in 
large studies but may prove to be effective in the future. Mineralocorticoids or high-dose 
hydrocortisone may reduce stomal output in patients with a retained ileum. 
Some authors recommend that the management algorithm of a high output ileostomy 
should include exclusion of small bowel C. difficile, particularly in inflammatory bowel 
disease patients with a history of previous infection [10]. If Clostridium toxins are found, 
treatment with oral metronidazole or vancomycin may result in quick resolution of 
symptoms. 
We present a case of high output stoma following bowel resection which was managed 
by adequate rehydration and proton pump inhibitors. This case highlights the importance 
of closely following and advising this group of patients with such stomas in order to 
prevent and identify as early as possible such complications. 
 
 
 
Table 1. Initial blood investigations 
Test Result  Normal 
Haemoglobin 10.1 11.5–16  g/dl 
Platelets  463  150–400 × 10
9/l 
WCC  10.1  4–11 × 10
9/l 
Urea 24.3  2.5–6.7  mmol/l 
Creatinine 113  70–150  μmol/l 
Sodium 120  135–145  mmol/l 
Potassium 4.7  3.5–5  mmol/l 
Chloride 87  95–105  mmol/l 
pH 7.29  7.35–7.45 
pCO2 24  35–45  mm  Hg 
pO2 77.1  75–100  mm  Hg 
BE –13.9  2  mmol/l 
HCO3
– 14  24–30  mmol/l 
SpO2 94.2  94–100% 
D-dimer negative   
Initial blood investigations reveal a hypochloraemic metabolic 
acidosis and hyponatraemia on a background of dehydration. 
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